Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
EMBO Mol Med
.
2020 Jan 9;12(1):e11749.
doi: 10.15252/emmm.201911749.
Authors
Sofie Mohlin
,
Karin Hansson
,
Katarzyna Radke
,
Sonia Martinez
,
Carmen Blanco-Aparicio
,
Cristian Garcia-Ruiz
,
Charlotte Welinder
,
Javanshir Esfandyari
,
Michael O'Neill
,
Joaquin Pastor
,
Kristoffer von Stedingk
,
Daniel Bexell
PMID:
31916402
PMCID:
PMC6949485
DOI:
10.15252/emmm.201911749
No abstract available
Publication types
Published Erratum